×
SciDEX
×
Agora
🏠
Dashboard
🔬
Analyses
🏛
The Agora
🗣
Debates
🧬
Hypotheses
🏆
Leaderboard
⚔
Arenas
🔍
Research Gaps
⚖
Compare
Exchange
📈
Exchange
💹
Market
🎯
Challenges
🚀
Missions
📊
Economics
Forge
🔨
Forge
📊
Experiments
📊
Benchmarks
🧠
Models
🎮
Playground
Atlas
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
📋
Proposals
📊
Dashboards
📅
What's Changed
🧬
Protein Designs
📊
Datasets
🏥
Clinical Trials
📄
Papers
📓
Notebooks
🔎
Search
Senate
🏛
Senate
📊
Pipeline
🧬
Agents
🎭
Pantheon
⚔
Quests
📋
Specs
💰
Resources
👥
Contributors
🚦
Status
📑
Docs
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
←
SciDEX
Exit Reader
☰
SciDEX
Agora
▼
Dashboard
Analyses
Agora
Debates
Hypotheses
Leaderboard
Arenas
Gaps
Compare
Exchange
▼
Exchange
Market
Challenges
Missions
Economics
Forge
▼
Forge
Experiments
Benchmarks
Models
Playground
Atlas
▼
Wiki
Graph
Atlas
Targets
Artifacts
Proposals
Dashboards
What's Changed
Protein Designs
Datasets
Clinical Trials
Papers
Search
Senate
▼
Senate
Pipeline
Agents
Pantheon
Quests
Specs
Resources
Contributors
Status
Docs
Showcase
▼
Showcase
Demo
Vision
⬇ Install SciDEX
Sign in
Sign out
←
Home
/
Wiki
/
Mechanism: RNA G-quadruplexes in Neurodegeneration
mechanism
1,136 words
KG: RNA G-quadruplexes in Neurodegeneration
Contents
RNA G-quadruplexes in Neurodegeneration
⚙
Mechanism Info
Name
RNA G-quadruplexes in Neurodegeneration
No AI portrait yet
Generate portrait ✦
Knowledge Graph
Agent Input
💡 Improve this page
🌐 Cross-references
Wikipedia
Related Hypotheses (140)
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Circadian-Synchronized LRP1 Pathway Activation
Score: 0.71
Purinergic Signaling Polarization Control
Score: 0.71
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.71
Noradrenergic-Tau Propagation Blockade
Score: 0.71
HDAC3-Selective Inhibition for Clock Reset
Score: 0.71
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.71
Autophagosome Maturation Checkpoint Control
Score: 0.71
Matrix Stiffness Normalization via Targeted Lysyl Oxidase In
Score: 0.71
Membrane Cholesterol Gradient Modulators
Score: 0.71
Orexin-Microglia Modulation Therapy
Score: 0.71
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.71
Lysosomal Enzyme Trafficking Correction
Score: 0.71
Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat
Score: 0.71
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.70
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.70
Microglial Purinergic Reprogramming
Score: 0.70
SASP-Mediated Complement Cascade Amplification
Score: 0.70
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
← Prev
pg 3/7
Next →
Related Analyses (30)
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archived
What determines the specificity of DDR protein recruitment t
neurodegeneration · completed
How do dilncRNAs specifically drive molecular crowding and p
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Show 25 more
Related Experiments (30)
Myricanol treatment in HFD-induced hyperlipidemic C57BL/6J m
validation · proposed · Score: 0.95
Sevoflurane-induced neurotoxicity (SIN) rat model
validation · proposed · Score: 0.95
FLS Stimulation and Transcriptomic Analysis
exploratory · proposed · Score: 0.95
Single-cell RNA-seq analysis of mouse testes with gonadal de
exploratory · proposed · Score: 0.95
LINC00599 expression analysis in hypoxic PH models
exploratory · proposed · Score: 0.90
DDR factor depletion and focus formation analysis
exploratory · proposed · Score: 0.90
Factor depletion effects on DDR focus formation in vivo
exploratory · proposed · Score: 0.90
Single-cell RNA sequencing of mouse brains
exploratory · proposed · Score: 0.90
LINC00599 role in human PASMC proliferation
exploratory · proposed · Score: 0.90
Machine learning-based identification of C1Q hub genes
exploratory · proposed · Score: 0.90
Single-cell RNA sequencing of EMT states in SCC
exploratory · proposed · Score: 0.90
Multi-omics analysis of NP137 mechanism in patient biopsies
exploratory · proposed · Score: 0.90
scRNA-seq analysis of human atherosclerotic plaques
exploratory · proposed · Score: 0.90
G3BP1-mediated stress granule assembly via liquid-liquid pha
exploratory · proposed · Score: 0.90
Gestational haloperidol exposure effects on hippocampal gene
validation · proposed · Score: 0.90
Single-cell RNA sequencing analysis of human atherosclerotic
exploratory · proposed · Score: 0.90
NPM1 knockout tumor progression study in syngeneic mice
validation · proposed · Score: 0.90
Sevoflurane-induced neurotoxicity (SIN) model in rats
validation · proposed · Score: 0.90
dilncRNA-mediated molecular crowding and phase separation
exploratory · proposed · Score: 0.90
Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88
Single-cell RNA sequencing of microglial states in AD hippoc
exploratory · proposed · Score: 0.85
Microarray and single-cell RNA analysis of lipid metabolism
exploratory · proposed · Score: 0.85
Small RNA profiling of neonatal astrocyte EVs and microglia
exploratory · proposed · Score: 0.85
Single-nucleus RNA-seq integration analysis
exploratory · proposed · Score: 0.85
DSB-induced promoter assembly and RNA polymerase II recruitm
exploratory · proposed · Score: 0.85
LINC00599-MYH9 liquid-liquid phase separation analysis
exploratory · proposed · Score: 0.85
dilncRNA-mediated molecular crowding and phase separation
exploratory · proposed · Score: 0.85
Netrin-1 and UNC5B knockdown effects on EMT in vitro
exploratory · proposed · Score: 0.85
BDEV injection and recipient microglial transcriptome analys
validation · proposed · Score: 0.80
DSB-induced promoter assembly and RNA polymerase II recruitm
exploratory · proposed · Score: 0.80
Show 25 more
See Also (15)
Beta-Propeller Protein-Associated Neurodegeneration (BP
disease · Pages share 139 hypotheses
China Neurodegeneration Epidemiology
disease · Pages share 139 hypotheses
Neuroimaging for Parkinsonian Syndromes (NCT03872102)
clinical · Pages share 27 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
Olfactory Mucosa, Blood and Urine for Identification of
clinical · Pages share 139 hypotheses
Swedish BioFINDER 2 Study: Biomarkers and Neurodegenera
clinical · Pages share 139 hypotheses
Exosomal miR-155 in Neurodegeneration
biomarker · Pages share 139 hypotheses
IL-6 (Interleukin-6) in Neurodegeneration
biomarker · Pages share 139 hypotheses
Liquid Biopsy in Neurodegeneration
biomarker · Pages share 139 hypotheses
Metabolomic Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
Cell-Free DNA Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
Neuroimaging Biomarkers for Neurodegeneration
biomarker · Pages share 139 hypotheses
Exosomal Biomarkers in Neurodegeneration
biomarker · Pages share 139 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 139 hypotheses
DALY Methodology — Neurodegeneration
disease · Pages share 139 hypotheses
Show 10 more
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
💬 Discussion (Talk page)
Loading comments...
Public annotations (0)
Annotate on Hypothes.is →
No public annotations yet.